Menu
Our investment strategy is focused on positively impacting healthcare and bending the curve of neurodegenerative disorders, mental health, and obesity. We invest in mission-aligned early-stage companies and deliver robust leadership and support services, positioning our partners for venture-scale returns and global impact.
We believe that we are stronger together, and through the Stead Innovators Network, we create opportunities for mentorships, strategic partnerships between our for-profits and nonprofits, and best-practice training across vital start-up topics and needs.
ALZpath is a passionate, diverse, and focused group of medical researchers, healthcare professionals, and renowned scientific advisors dedicated to transforming the Alzheimer’s disease ecosystem through timely diagnosis.
The Amydis team is developing ocular tracers for immediate detection of degenerative and systemic diseases. This pioneering technology can accelerate diagnosis, improve the clinical testing of novel therapeutics, and revolutionize treatment.
Atlas Meditech is a leading developer of clinical decision support and intelligent care augmentation solutions, driving innovation in patient care. Its flagship the Neurosurgical Atlas is the largest non-profit organization for neurosurgical education and research in the world, dedicated to advancing the field of neurosurgery through comprehensive multimedia educational resources.
Cato’s mission is to reimagine the medical supply chain through transformative technologies. The company builds trust through transparency and reliability, delivering the highest value to healthcare customers while giving back to the community.
Spinogenix is developing a
new class of regenerative therapeutics to restore memory and motor functions lost in neurodegenerative and psychiatric diseases and is advancing the first synaptic regenerative therapy in Alzheimer’s disease.
Committed to elevating caregiving for the cognitively impaired, TapRoot is transforming how caregivers care for family members living with dementia through person-centered behavioral interventions and cutting-edge technology.
Follow news from our portfolio companies on LinkedIn
Sign up for our Stead Innovators email newsletter today.